Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3435739 | American Journal of Obstetrics and Gynecology | 2009 | 6 Pages |
Abstract
Our data demonstrated that nuclear cyclin B1 is overexpressed in low-malignant-potential tumors, which may contribute to the development of low-malignant-potential tumors. Cyclin B1 and G1 may not be suitable targets for epithelial ovarian cancer treatment.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Hong MD, PhD, Wei MD, PhD, Michael T. MD, De-Yu MS, Siqing MD, PhD, Yan-Fang MD, John J. MD,